Literature DB >> 16198456

Oral vaccine that breaks the transmission cycle of the Lyme disease spirochete can be delivered via bait.

Maria J C Gomes-Solecki1, Dustin R Brisson, Raymond J Dattwyler.   

Abstract

Borrelia burgdorferi causes Lyme disease, a potentially debilitating human disease for which no vaccine is currently available. We developed an oral bait delivery system for an anti-B. burgdorferi vaccine based in OspA. Mice were immunized orally via gavage and bait feeding. Challenge was performed via Ixodes scapularis field nymphs carrying multiple B. burgdorferi strains. Vaccination protected 89% of the mice and the systemic immune response was skewed toward IgG2a/2b production. Moreover, this oral vaccine reduced the pathogen in the tick vector by eight-fold. We conclude that this oral vaccine induces a protective systemic immune response against a variety of infectious B. burgdorferi strains found in nature and therefore it can eliminate this zoonotic pathogen from its major host reservoirs. Because we observed elimination of the spirochete from the tick vector, a broad delivery of this oral vaccine to wildlife reservoirs is likely to disrupt the transmission cycle of this pathogen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16198456     DOI: 10.1016/j.vaccine.2005.08.089

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  38 in total

1.  Evidence for Personal Protective Measures to Reduce Human Contact With Blacklegged Ticks and for Environmentally Based Control Methods to Suppress Host-Seeking Blacklegged Ticks and Reduce Infection with Lyme Disease Spirochetes in Tick Vectors and Rodent Reservoirs.

Authors:  Lars Eisen; Marc C Dolan
Journal:  J Med Entomol       Date:  2016-09-01       Impact factor: 2.278

Review 2.  Tick vaccines and the transmission of tick-borne pathogens.

Authors:  J de la Fuente; K M Kocan; E F Blouin
Journal:  Vet Res Commun       Date:  2007-08       Impact factor: 2.459

3.  Development of a baited oral vaccine for use in reservoir-targeted strategies against Lyme disease.

Authors:  Debaditya Bhattacharya; Mekki Bensaci; Kathryn E Luker; Gary Luker; Steven Wisdom; Sam R Telford; Linden T Hu
Journal:  Vaccine       Date:  2011-08-02       Impact factor: 3.641

4.  Reduction of tick infections with Anaplasma marginale and A. phagocytophilum by targeting the tick protective antigen subolesin.

Authors:  José de la Fuente; Consuelo Almazán; Edmour F Blouin; Victoria Naranjo; Katherine M Kocan
Journal:  Parasitol Res       Date:  2006-07-01       Impact factor: 2.289

5.  Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.

Authors:  Mark R Scheckelhoff; Sam R Telford; Linden T Hu
Journal:  Vaccine       Date:  2005-11-04       Impact factor: 3.641

6.  Evaluation of the effect of host immune status on short-term Yersinia pestis infection in fleas with implications for the enzootic host model for maintenance of Y. pestis during interepizootic periods.

Authors:  Christine B Graham; Michael E Woods; Sara M Vetter; Jeannine M Petersen; John A Montenieri; Jennifer L Holmes; Sarah E Maes; Scott W Bearden; Kenneth L Gage; Rebecca J Eisen
Journal:  J Med Entomol       Date:  2014-09       Impact factor: 2.278

7.  Reservoir targeted vaccine against Borrelia burgdorferi: a new strategy to prevent Lyme disease transmission.

Authors:  Luciana Meirelles Richer; Dustin Brisson; Rita Melo; Richard S Ostfeld; Nordin Zeidner; Maria Gomes-Solecki
Journal:  J Infect Dis       Date:  2014-02-11       Impact factor: 5.226

Review 8.  Borrelia burgdorferi and tick proteins supporting pathogen persistence in the vector.

Authors:  Faith Kung; Juan Anguita; Utpal Pal
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

9.  Reductions in human Lyme disease risk due to the effects of oral vaccination on tick-to-mouse and mouse-to-tick transmission.

Authors:  Maarten J Voordouw; Haley Tupper; Özlem Önder; Godefroy Devevey; Christopher J Graves; Brian D Kemps; Dustin Brisson
Journal:  Vector Borne Zoonotic Dis       Date:  2013-02-21       Impact factor: 2.133

10.  Immune response to Lactobacillus plantarum expressing Borrelia burgdorferi OspA is modulated by the lipid modification of the antigen.

Authors:  Beatriz del Rio; Jos F M L Seegers; Maria Gomes-Solecki
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.